CN104958493A - Medicine for treating mammary gland hyperplasia - Google Patents
Medicine for treating mammary gland hyperplasia Download PDFInfo
- Publication number
- CN104958493A CN104958493A CN201510415675.7A CN201510415675A CN104958493A CN 104958493 A CN104958493 A CN 104958493A CN 201510415675 A CN201510415675 A CN 201510415675A CN 104958493 A CN104958493 A CN 104958493A
- Authority
- CN
- China
- Prior art keywords
- medicine
- processed
- prepared
- blood
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicine for treating mammary gland hyperplasia. The medicine is prepared from the following raw materials: pangolin scales, dragon's blood, nutgrass galingale rhizome, ground beetle, American ginseng, prepared frankincense and prepared myrrh. According to different characteristics of Chinese herbal materials, the Chinese herbal materials are processed into powder respectively, the powered Chinese herbal materials are proportionally blended and evenly mixed, and the mixture is prepared into powder or pills after being sterilized. The medicine has the advantages of simple and convenient administration, short treatment period, high cure rate, consolidated curative effect, no toxic or side effect, no contraindication and low treatment cost.
Description
Technical field
The present invention relates to a kind of medicine, is specifically a kind of Chinese patent medicine for the treatment of cyclomastopathy prepared by raw material with Chinese medicine.
Background technology
Cyclomastopathy also claims cystic hyperplasia of breast, and cyclomastopathy is commonly encountered disease, is multiplely born between 20-40 year.The clinical manifestation of this disease is that distending pain of the breast weight differs, and distending pain has periodically, often adds and overweights premenstrua.Lump in breast can be sent out in side, also can bilateral.Or multiple, also can be limited to a breast part, also can branch in whole breast.Lay one's hand on mammary swelling agllutination nodular when looking into not of uniform size, matter is tough and hard, and there is no adhesion between skin and deep tissue and be pushed, but unclear in the boundary of surrounding tissue.Expansion block may reduce to some extent in menstruation, and axillary gland does not swell.In addition, this course of disease is longer, and development is slow, and nipple discharge are also common sympton.Because the clinical symptoms of this disease and menstrual cycle have close relationship, therefore, it is generally acknowledged that the ovarian dysfunction that betides of this disease has relation.Lutein secretion reduces, and amount of estrogen just increases relatively.According to above clinical manifestation, the diagnosis of this disease is not so difficult.But minority can not cancerate, therefore, the check of reply patient every three months once, is carried out or tissue slice inspection if desired.
At present, doctor trained in Western medicine there is no effective treatment way to cyclomastopathy, has people to suppress estrogen with androgen, and softening tuberosity eases the pain, or with 5% potassium iodide alleviating pain.The side effect of the hormone therapy such as methyl testosterone, testosterone propionate is the detailed balance upset further between human hormone, unsuitable conventional application, is not able to just consider to use when only affecting work or life when pain is serious." breast peace sheet " that Chinese medicine has Zhengzhou Rui Long drugmaker to produce, its ingredient is Concha Ostreae, the Radix Astragali, Rhizoma Sparganii, Fructus Hordei Germinatus, Radix Asparagi, Myrrha, Herba Epimedii, Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, Sargassum, Radix Bupleuri, Rhizoma Curcumae, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae Viride, Olibanum.Function cures mainly: regulating the flow of QI to dissipate blood stasis, hard masses softening and resolving.For the nodules of the breast person that belongs to syndrome of qi stagnation and blood stasis.Rhizoma Sparganii, Fructus Hordei Germinatus, Myrrha, the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, Rhizoma Curcumae, Endothelium Corneum Gigeriae Galli, Pericarpium Citri Reticulatae Viride, frankincense powder are broken into fine powder, the Six-elements such as all the other Concha Ostreaes decoct with water three times, 2 hours first times, second time 1.5 hours, 1 hour third time, gradation is filtered, merging filtrate is also evaporated to the thick paste that relative density is 1.30-1.35 (60 DEG C), adds above-mentioned fine powder, mixing, dry, be ground into fine powder, sieve, add lactose, hydroxypropyl cellulose, carboxymethyl starch sodium, magnesium stearate, mixing, with alcohol granulation, dry, tabletting, film coating, to obtain final product.The additives such as hydroxypropyl cellulose, the situation of untoward reaction happens occasionally to cause some patients to occur.This ingredient is more, concocts loaded down with trivial details, and only for syndrome of qi stagnation and blood stasis patient, adaptive surface is narrower.
Summary of the invention
Task of the present invention is to provide a kind of making simply, and wide accommodation, take easy, treatment cycle is short, and cure rate is high, and efficacy consolidation has no side effect, without the medicine of the treatment cyclomastopathy of taboos disease.
Medicine of the present invention is made up (consumption is weight portion) of following component:
Squama Manis 100-120, Sanguis Draxonis 50-70, Rhizoma Cyperi 180-200, eupolyphaga 70-90,
Radix Panacis Quinquefolii 130-150, Olibanum (processed) 190-210, Myrrha (processed) 190-210.
Formula preferred weight (part) ratio range preparing medicine of the present invention is:
Squama Manis 100-110, Sanguis Draxonis 50-65, Rhizoma Cyperi 180-190, eupolyphaga 75-90,
Radix Panacis Quinquefolii 135-145, Olibanum (processed) 190-200, Myrrha (processed) 190-200.
Optimum weight (part) proportioning of medicine of the present invention is:
Squama Manis 110, Sanguis Draxonis 60, Rhizoma Cyperi 190, eupolyphaga 80, Radix Panacis Quinquefolii 140, Olibanum (processed) 200, Myrrha (processed) 200.
By the preparation method that above-mentioned each component makes medicine of the present invention be: select required lustration raw material medicine, be processed into Powdered respectively, the powder of above seven flavor medicine, prepares in proportion, mix homogeneously, after sterilizing, makes powder; Also honeyed pill or watered pill dosage form can be can be made into Mel or water.
Hyperplasia of mammary glands belongs to " nodules of the breast " category of motherland's medical science, with liver, stomach, punching, appoint etc. passages through which vital energy circulates have close relationship.Incoordination between the liver and stomach person, often has the not smooth history of feelings, depression of liver-QI before disease, strongly fragrant in stomach, therefore the often growth and decline with susceptible to anger of breast expansion block; Disharmony of Chong and Conception Channels person, often have menoxenia history, CHONG meridian being the blood pool, REN meridian connecting with the uterus and pregnancy, therefore distending pain of the breast often changes with menstrual cycle.Manyly again reduce phlegm because of damaged by excess of seven emotions, the stagnation of QI, hyperamization knot blood stasis becomes the solidifying knot of stopping up of disease to gather form hyperplasia of mammary glands in breast.The rule for the treatment of is with depressed liver-energy dispersing and QI regulating and according to state of an illness assistant with blood circulation promoting and blood stasis dispelling or dissipating phlegm and resolving masses method for it.
In prescription of the present invention: Squama Manis: salty, be slightly cold.Return liver, stomach warp.Effect: blood circulation promoting and blood stasis dispelling, eliminating carbuncle toxin expelling, specially can manage it loose, the meridian dredging reaches disease institute.Sanguis Draxonis: sweet, salty, flat.Return pericardium channel.Enter conscience blood system.Effect: dissipating blood stasis tissue regeneration promoting, dehematize carbuncle, only carbuncle granulation promoting.Rhizoma Cyperi: pungent, micro-hardship, micro-sweet, returns tri-jiao channel.Effect: depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving.Eupolyphaga: salty, pungent.Return Liver Channel.Effect: removing blood stasis, hard masses softening and resolving.Radix Panacis Quinquefolii: sweet, micro-hardship is cool.GUIXIN, lung, kidney channel.Effect: lung benefiting sun, clearind deficient heat, cool in nature and mend.Olibanum (processed): acrid, bitter, warm.Enter the heart, liver,spleen,kidney warp.Effect: blood circulation promoting and blood stasis dispelling, loose blood detumescence, analgesic therapy granulation promoting.Myrrha (processed): bitter, pungent, flat.Enter the heart, liver,spleen,kidney warp.Effect: blood circulation promoting and blood stasis dispelling, loose blood detumescence, analgesic therapy granulation promoting.
Prescription Squama Manis in prescription of the present invention, blood circulation promoting and blood stasis dispelling, detumescence toxin expelling, eupolyphaga, removing blood stasis, hard masses softening and resolving.The two be the in love product of flesh and blood, and specially can manage it and fall apart, the meridian dredging reaches disease institute, therefore is monarch drug.Sanguis Draxonis, dissipating blood stasis tissue regeneration promoting, dehematize carbuncle, granulation promoting of unstinging; Olibanum (processed) promoting blood circulation and stopping pain, detumescence and promoting granulation, muscle relaxing collaterals activating; Myrrha (processed), blood circulation promoting and blood stasis dispelling, loose blood, reducing swelling and alleviating pain.Olibanum (processed) Myrrha (processed) perfume (or spice) can be walked to go here and there and benefaction, blood diarrhea due to disorder of QI, and three medicines share dissipating blood stasis tissue regeneration promoting, and detumescence relieves the pain, and pain of dispelling granulation promoting is ministerial drug.Radix Panacis Quinquefolii, lung benefiting sun, disappear deficiency-heat, qi and blood tonifying; Rhizoma Cyperi, depressed liver-energy dispersing and QI regulating is adjuvant.Reasonable recipe of the present invention, according to theory of Chinese medical science, take depressed liver-energy dispersing and QI regulating as mark, and blood circulation promoting and blood stasis dispelling, hard masses softening and resolving is this, and all medicines share and are applicable to various types of cyclomastopathy.
Medicine of the present invention shows through result in clinical application, has following advantage:
1, make simply, wide accommodation.
2, take easy, treatment cycle is short, and cure rate is high, efficacy consolidation.
3, have no side effect, without taboos disease.
4, medical expense is few.
Instructions of taking of the present invention and dose: 3 times on the one, a 3-5 gram 30 days is a course for the treatment of.General 2-3 can cure a course for the treatment of.
For showing the therapeutic effect of medicine of the present invention to cyclomastopathy, the present invention is through clinical observation, and take breast peace sheet and medicine of the present invention respectively, observe 2-3 the course for the treatment of (30 days course for the treatment of), clinical test results is in table 1.
Table 1 clinical comparison data
Can show that medicine of the present invention is to cyclomastopathy effective percentage 98% from table 1, cure rate 88%, invalid 2%.
Embodiment
Raw material (kilogram) is taken by following proportioning:
Squama Manis 110, Sanguis Draxonis 60, Rhizoma Cyperi 190, eupolyphaga 80,
Radix Panacis Quinquefolii 140, Olibanum (processed) 200, Myrrha (processed) 200.
Production method is as follows:
Choose required lustration raw material medicine, carry out respectively screening, dry, pulverize, prepare in proportion, mix homogeneously, after ultraviolet radiation for sterilizing and disinfecting, make powder.
Claims (4)
1. treat a medicine for cyclomastopathy, it is characterized in that it is the medicament be made up of the raw material of following weight proportioning:
Squama Manis 100-120, Sanguis Draxonis 50-70, Rhizoma Cyperi 180-200, eupolyphaga 70-90,
Radix Panacis Quinquefolii 130-150, Olibanum (processed) 190-210, Myrrha (processed) 190-210.
2. the medicine for the treatment of cyclomastopathy according to claim 1, wherein the weight proportion of each raw material is:
Squama Manis 100-110, Sanguis Draxonis 50-65, Rhizoma Cyperi 180-190, eupolyphaga 75-90,
Radix Panacis Quinquefolii 135-145, Olibanum (processed) 190-200, Myrrha (processed) 190-200.
3. the medicine for the treatment of cyclomastopathy according to claim 1, wherein the weight proportion of each raw material is:
Squama Manis 110, Sanguis Draxonis 60, Rhizoma Cyperi 190, eupolyphaga 80, Radix Panacis Quinquefolii 140, Olibanum (processed) 200,
Myrrha (processed) 200.
4. the medicine of the treatment cyclomastopathy according to claim 1,2 or 3, is characterized in that said medicine is powder or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510415675.7A CN104958493A (en) | 2015-07-08 | 2015-07-08 | Medicine for treating mammary gland hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510415675.7A CN104958493A (en) | 2015-07-08 | 2015-07-08 | Medicine for treating mammary gland hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104958493A true CN104958493A (en) | 2015-10-07 |
Family
ID=54212696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510415675.7A Pending CN104958493A (en) | 2015-07-08 | 2015-07-08 | Medicine for treating mammary gland hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104958493A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1253824A (en) * | 1999-10-15 | 2000-05-24 | 魏玉锁 | Chinese medicine preparation for curing hyperplasia of mamary glands and its preparation method |
| CN1698736A (en) * | 2005-04-28 | 2005-11-23 | 李建柱 | Externally applied medicine for treating mammary glands hyperplasia and preventing mammary cancer |
-
2015
- 2015-07-08 CN CN201510415675.7A patent/CN104958493A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1253824A (en) * | 1999-10-15 | 2000-05-24 | 魏玉锁 | Chinese medicine preparation for curing hyperplasia of mamary glands and its preparation method |
| CN1698736A (en) * | 2005-04-28 | 2005-11-23 | 李建柱 | Externally applied medicine for treating mammary glands hyperplasia and preventing mammary cancer |
Non-Patent Citations (2)
| Title |
|---|
| 于来荣: "中西医结合治疗乳腺增生病46例", 《山东中医杂志》 * |
| 吴国柱等: "乳癖汤治疗乳腺增生病202例", 《中国中西医结合外科杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1302801C (en) | Compound traditional Chinese medicine formulation for curing hysteromyoma | |
| CN101411848B (en) | Black plaster for treating gland hyperplasia and preparation method thereof | |
| CN102526691A (en) | External application plaster for treating dysmenorrhea | |
| CN101912575B (en) | External medicament for treating painful swelling of joints and gout diseases and preparation process thereof | |
| CN101337048B (en) | Medicine for treating hyperplasia of mammary glands | |
| CN103341096B (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN102552608B (en) | Medicine composition used for treating fracture and bone injury, preparation method thereof, and purpose thereof | |
| CN103006879B (en) | Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof | |
| CN106390077A (en) | Pharmaceutical composition for treating stomachache and diarrhea and preparation method and application thereof | |
| CN106177725A (en) | A kind of treat the plaster compositions of mastopathy, purposes and preparation method thereof | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN103157055A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
| CN103191369B (en) | Chinese medicinal composition for treating mammary gland hyperplasia | |
| CN104958493A (en) | Medicine for treating mammary gland hyperplasia | |
| CN105748646A (en) | Traditional Chinese medicine composition for treating pain in neck or shoulders or waist or legs and preparation method thereof | |
| CN102266456B (en) | Medicament for treating orthopedic disease and preparation thereof | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN101375955B (en) | Sperm-passing formulation for treating non-ejaculation symptom and preparation method thereof | |
| CN110051812A (en) | A kind of strengthening vital QI to eliminate pathogenic factors Chinese medicine and preparation method thereof | |
| CN104225282A (en) | Traditional Chinese medicine for treating postpartum headache | |
| CN1682937A (en) | Medicine for treating mammary gland lobule proliferation and its preparing process | |
| CN104758835B (en) | A kind of Chinese medicine being used for the treatment of cerebral infarction disease | |
| CN102872287A (en) | Traditional Chinese medicine composition for treating femoral head necrosis and preparation method thereof | |
| CN106237101A (en) | A kind of Chinese medicine formula treating breast carcinoma | |
| CN100486638C (en) | Medicament for treating hyperplasia of mammary glands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151007 |
|
| WD01 | Invention patent application deemed withdrawn after publication |